Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/22/21 → 1/22/24 |
Funding
- Medpace Clinical Research LLC ((OE) Prot #P-106-001 // (OE) Prot #P-106-001)
- AlloVir, Inc ((OE) Prot #P-106-001 // (OE) Prot #P-106-001)
Prot #P-106-001: Phase 1/2, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ALVR106 in Addition to Standard of Care for the Treatment of High-Risk Patients with Respiratory Viral Infections After Hematopoietic Cell Transplant
- Frankfurt, Olga (PD/PI)
Project: Research project